ProKidney Corp. (NASDAQ:PROK) People

ProKidney Corp.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chamath Palihapitiya
Other companies: Colombier Acquisition Corp. III (Director · Since at least Feb 3, 2026); American Exceptionalism Acquisition Corp. A (Director · Since at least Sep 25, 2025); Akili Inc (Director · Jul 2, 2021 – May 2, 2023 · Past); Social Capital Suvretta Holdings Corp II (President, Director · Jul 2, 2021 – Aug 16, 2021 · Past); Social Capital Suvretta Holdings Corp IV (President, Director · Jul 2, 2021 – Aug 16, 2021 · Past); Social Capital Hedosophia Holdings Corp IV (CEO & Chairman of the Board, Director · Oct 8, 2020 – Oct 8, 2020 · Past); Social Capital Hedosophia Holdings Corp VI (CEO & Chairman of the Board, Director · Oct 8, 2020 – Oct 8, 2020 · Past); SoFi Technologies, Inc. (CEO & Chairman of the Board, Director · Oct 8, 2020 – Oct 8, 2020 · Past); Opendoor Technologies Inc (CEO & Chairman of the Board, Director · Apr 27, 2020 – Apr 27, 2020 · Past); Clover Health Investments, Corp. (CEO & Chairman of the Board, Director · Apr 21, 2020 – Apr 21, 2020 · Past); Slack Technologies Inc (Director · Jun 7, 2019 – Dec 10, 2019 · Past); Virgin Galactic Holdings, Inc. (Director · Sep 13, 2017 – Mar 18, 2021 · Past)
President, Director · Jul 2, 2021 – Aug 16, 2021 · Past
John M. Maraganore
Other companies: City Therapeutics, Inc. (Executive Chair · Since at least Oct 19, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Jan 29, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Jun 6, 2024); Kymera Therapeutics, Inc. (Director · Since at least Jan 17, 2022); Beam Therapeutics Inc. (Board Member · Since at least Nov 5, 2021); Alnylam Pharmaceuticals, Inc. (Director · Since at least May 12, 2006); Instil Bio, Inc. (Director · Jun 11, 2025 – Nov 4, 2026 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Dec 31, 2022 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Sep 14, 2017 · Past); Regulus Therapeutics Inc (Director · Oct 4, 2012 – Oct 10, 2012 · Past)
Director · Jul 11, 2022 – Jun 29, 2023 · Past
James Ryans
Other companies: Akili Inc (Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past); Social Capital Suvretta Holdings Corp II (Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past); Social Capital Suvretta Holdings Corp IV (Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past); Social Capital Hedosophia Holdings Corp IV (Chief Financial Officer · May 31, 2021 – May 31, 2021 · Past); Social Capital Hedosophia Holdings Corp VI (Chief Financial Officer · May 31, 2021 – May 31, 2021 · Past); Clover Health Investments, Corp. (Director · Apr 21, 2020 – Apr 21, 2020 · Past); Virgin Galactic Holdings, Inc. (Director · Feb 5, 2018 – Dec 16, 2020 · Past)
Chief Financial Officer · Jun 29, 2021 – Jun 29, 2021 · Past
Jennifer Fox
Other companies: Zenas BioPharma, Inc. (See Remarks · Since at least Sep 12, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Nuvation Bio Inc. (Chief Financial Officer · Feb 10, 2021 – Feb 28, 2023 · Past)
Director · Since at least Jul 11, 2022
Marc Semigran
Other companies: Edgewise Therapeutics, Inc. (Chief Development Officer · Dec 19, 2022 – Dec 24, 2024 · Past); MyoKardia Inc (Chief Medical Officer · Dec 1, 2016 – Feb 8, 2019 · Past)
Director · Jun 29, 2021 – Jun 29, 2021 · Past
Mary Weger
Other companies: Medidata Solutions Inc (EVP, Human Resources · Feb 23, 2017 – Feb 24, 2017 · Past); Aegerion Pharmaceuticals Inc (Chief Performance Officer · Mar 29, 2015 – Aug 4, 2015 · Past)
Chief People Officer · Dec 1, 2022 – Jan 16, 2023 · Past
Timothy Bertram
Other companies: NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Tengion Inc (Pres Rsrch & Dev, & Chf Sc Ofc · Apr 9, 2010 – Mar 4, 2013 · Past)
Chief Executive Officer, Director · Jul 11, 2022 – Jan 16, 2023 · Past
Todd C. Girolamo
Other companies: Longeveron Inc. (Director · Feb 15, 2022 – Dec 21, 2022 · Past); Lisata Therapeutics, Inc. (CLO, SVP of Corp Dev · Jun 17, 2021 – Jan 13, 2022 · Past)
Chief Legal Officer and Secretary · Since at least Jul 11, 2022
Brian J. G. Pereira
Other companies: KalVista Pharmaceuticals, Inc. (Director · Since at least Oct 3, 2024)
Director · Since at least May 30, 2024
William Doyle
Other companies: NovoCure Limited (Executive Chairman · Since at least Dec 22, 2025)
Lead Independent Director · Since at least Nov 19, 2026
Alan M. LotvinBoard Member · Since at least Nov 19, 2026
Bruce CulletonChief Executive Officer, Director · Since at least Mar 1, 2026
Carla PoulsonChief People Officer · Since at least Nov 19, 2026
Darin J. WeberChief Regulatory Officer · Since at least Jul 11, 2022
Deepak JainChief Operating Officer · Jul 11, 2022 – Jan 16, 2023 · Past
Emily ButlerSVP, Biometrics · Since at least Nov 5, 2026
Farah AliChief Medical Officer · Since at least Nov 18, 2026
Greg MadisonChief Commercial Officer · Since at least Mar 25, 2026
Jake TreeseSVP, Head of Quality · Since at least Nov 19, 2026
James CoulstonChief Financial Officer · Since at least Mar 1, 2026
Joseph StavasSVP, Interventional Procedures · Since at least Nov 19, 2026
Ken LockeChief Technical Officer · Since at least Aug 10, 2026
Libbie Parker McKenzieChief Medical Officer · Jul 11, 2022 – Jan 16, 2023 · Past
Pablo LegorretaChairman of the Board · Since at least Nov 19, 2026
Richard WilliamsChief Information Officer · Since at least Nov 19, 2026
Santos Jose Ignacio JimenezDirector · Since at least Jul 11, 2022
Ulrich Peter Alfred ErnstEVP, Technical Operations · Mar 25, 2024 – Apr 1, 2024 · Past
Uma SinhaDirector · Since at least May 29, 2025